Catalyst Pharmaceuticals Potential Upside
| CPRX Stock | | | USD 31.15 -0.02 -0.06% |
Potential Upside is the amount of upward price movement an investor or an analyst expects of a particular equity instrument. Below is Catalyst Pharmaceuticals's current Potential Upside with peer comparisons and related risk metrics.
Current Potential Upside Value
Catalyst Pharmaceuticals's Potential Upside of 4.12 reflects modest estimated upside from current levels. Catalyst Pharmaceuticals trades near but slightly below the model-derived fair value estimate.
Potential Upside | = | 1PM2PM |
| = | 4.12 | |
| 1PM | = | First upper moment |
| 2PM | = | Second upper moment |
Potential Upside Peers Comparison
The peer group averages 5.82 for Potential Upside, with Catalyst Pharmaceuticals at 4.12 falling below that level. Readings span 2.92 (Apellis Pharmaceuticals) to 8.81 (Beam Therapeutics). Catalyst Pharmaceuticals shows less estimated upside from current levels than the peer average.
Potential Upside Relative To Other Indicators
The chart below plots Potential Upside against Maximum Drawdown for Catalyst Pharmaceuticals and its peers. Each point represents one equity — position along the horizontal axis shows Potential Upside while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Catalyst Pharmaceuticals's Maximum Drawdown of
10.95 runs about
2.66 times its Potential Upside of
4.12 . This indicates Maximum Drawdown is significantly higher than Potential Upside for Catalyst Pharmaceuticals.
Methodology, Assumptions & Data Sources
The current Potential Upside for Catalyst Pharmaceuticals is 4.12. Potential Upside for Catalyst Pharmaceuticals is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Catalyst Pharmaceuticals operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.
Other Technical Indicators